GSK 799943

Drug Profile

GSK 799943

Alternative Names: GSK-799943

Latest Information Update: 05 Mar 2008

Price : $50

At a glance

  • Originator GlaxoSmithKline
  • Class Antiasthmatics
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.


Highest Development Phases

  • Discontinued Allergic rhinitis; Asthma; Chronic obstructive pulmonary disease

Most Recent Events

  • 01 Dec 2004 Phase-II clinical trials in Chronic obstructive pulmonary disease (Inhalation)
  • 01 Dec 2004 Phase-II clinical trials in Asthma (Inhalation)
  • 01 Dec 2004 Discontinued - Phase-I for Allergic rhinitis (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top